{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T14:43:02Z","timestamp":1794840182096,"version":"4.9.1"},"reference-count":93,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Interleukin-18 (IL-18) is a potent pro-inflammatory cytokine that is involved in various innate and adaptive immune processes related to infection, inflammation, and autoimmunity. Therefore, it is described as a key mediator of autoinflammatory diseases associated with the development of macrophage activation syndrome (MAS), including systemic juvenile idiopathic arthritis and adult-onset Still\u2019s disease. This review focuses on the role of IL-18 in inflammatory responses, placing emphasis on autoinflammatory diseases associated with chronic excess of serum IL-18, which correlate with clinical and biological signs of the disease. Therefore, it is useful for the diagnosis and monitoring of disease activity. Researchers are currently investigating IL-18\u2019s role as a therapeutic target for the treatment of inflammatory diseases. The inhibition of IL-18 signaling through recombinant human IL-18BP (IL-18 binding protein) seems to be an effective therapeutic strategy, though further studies are necessary to clarify its importance as a therapeutic target.<\/jats:p>","DOI":"10.3390\/ijms241311125","type":"journal-article","created":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T00:34:30Z","timestamp":1688603670000},"page":"11125","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["IL-18 in Autoinflammatory Diseases: Focus on Adult Onset Still Disease and Macrophages Activation Syndrome"],"prefix":"10.3390","volume":"24","author":[{"given":"Chiara","family":"Baggio","sequence":"first","affiliation":[{"name":"Rheumatology Unit, Department of Medicine, University of Padova, 35128 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Bindoli","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Medicine, University of Padova, 35128 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Guidea","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Medicine, University of Padova, 35128 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0548-4983","authenticated-orcid":false,"given":"Andrea","family":"Doria","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Medicine, University of Padova, 35128 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4958-5105","authenticated-orcid":false,"given":"Francesca","family":"Oliviero","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Medicine, University of Padova, 35128 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6432-7174","authenticated-orcid":false,"given":"Paolo","family":"Sfriso","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Medicine, University of Padova, 35128 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"16957","DOI":"10.1073\/pnas.262663399","article-title":"The promoter of IL-18 binding protein: Activation by an IFN-\u03b3-induced complex of IFN regulatory factor 1 and CCAAT\/enhancer binding protein beta","volume":"99","author":"Hurgin","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"951535","DOI":"10.3389\/fimmu.2022.951535","article-title":"Pathogenic roles and diagnostic utility of interleukin-18 in autoinflammatory diseases","volume":"13","author":"Shimizu","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/imr.12616","article-title":"Interleukin-18: Biological properties and role in disease pathogenesis","volume":"281","author":"Kaplanski","year":"2018","journal-title":"Immunol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1073\/pnas.96.5.2256","article-title":"Gene expression, synthesis, and secretion of interleukin 18 and interleukin 1\u03b2 are differentially regulated in human blood mononuclear cells and mouse spleen cells","volume":"96","author":"Puren","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/art.41976","article-title":"Excess Serum Interleukin-18 Distinguishes Patients With Pathogenic Mutations in PSTPIP1","volume":"74","author":"Stone","year":"2022","journal-title":"Arthritis Rheumatol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Yasuda, K., Nakanishi, K., and Tsutsui, H. (2019). Interleukin-18 in Health and Disease. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20030649"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1359-6101(00)00015-0","article-title":"Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu","volume":"12","author":"Nakanishi","year":"2001","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3389\/fimmu.2013.00289","article-title":"Interleukin-18 and IL-18 Binding Protein","volume":"4","author":"Dinarello","year":"2013","journal-title":"Front. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1074-7613(00)80111-9","article-title":"Caspase-1-independent, Fas\/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice","volume":"11","author":"Tsutsui","year":"1999","journal-title":"Immunity"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5508","DOI":"10.4049\/jimmunol.1202121","article-title":"Cutting Edge: FAS (CD95) Mediates Noncanonical IL-1\u03b2 and IL-18 Maturation via Caspase-8 in an RIP3-Independent Manner","volume":"189","author":"Bossaller","year":"2012","journal-title":"J. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"26595","DOI":"10.1074\/jbc.272.42.26595","article-title":"Involvement of Caspase-1 and Caspase-3 in the Production and Processing of Mature Human Interleukin 18 in Monocytic THP.1 Cells","volume":"272","author":"Akita","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jdermsci.2010.05.004","article-title":"Granzyme B is a novel interleukin-18 converting enzyme","volume":"59","author":"Omoto","year":"2010","journal-title":"J. Dermatol. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"31371","DOI":"10.1074\/jbc.M802814200","article-title":"Prointerleukin-18 is activated by meprin beta in vitro and in vivo in intestinal inflammation","volume":"283","author":"Banerjee","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.4049\/jimmunol.167.3.1306","article-title":"An absolute requirement for STAT4 and a role for IFN-\u03b3 as an amplifying factor in IL-12 induction of the functional IL-18 receptor complex","volume":"167","author":"Nakahira","year":"2001","journal-title":"J. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1002\/1521-4141(200107)31:7<2236::AID-IMMU2236>3.0.CO;2-G","article-title":"IFN-\u03b1 and IL-18 synergistically enhance IFN-\u03b3 production in human NK cells: Differential regulation of Stat4 activation and IFN-\u03b3 gene expression by IFN-\u03b1 and IL-12","volume":"31","author":"Matikainen","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3389\/fimmu.2018.00763","article-title":"Unique Action of Interleukin-18 on T Cells and Other Immune Cells","volume":"9","author":"Nakanishi","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"6568","DOI":"10.4049\/jimmunol.167.11.6568","article-title":"Neutrophil Proteinase 3-Mediated Induction of Bioactive IL-18 Secretion by Human Oral Epithelial Cells","volume":"167","author":"Sugawara","year":"2001","journal-title":"J. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S1074-7613(00)80378-7","article-title":"IGIF does not drive Th1 development but synergizes with IL-12 for interferon-\u03b3 production and activates IRAK and NF\u03baB","volume":"7","author":"Robinson","year":"1997","journal-title":"Immunity"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.4049\/jimmunol.165.3.1307","article-title":"IL-18 activates STAT3 in the natural killer cell line 92, augments cytotoxic activity, and mediates IFN-\u03b3 production by the stress kinase p38 and by the extracellular regulated kinases p44erk-1 and p42erk-21","volume":"165","author":"Kalina","year":"2000","journal-title":"J. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/JLB.1HI1017-396RR","article-title":"Frontline Science: IL-18 primes murine NK cells for proliferation by promoting protein synthesis, survival, and autophagy","volume":"104","author":"Li","year":"2018","journal-title":"J. Leukoc. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cyto.2014.05.003","article-title":"Interleukin-18 directly protects cortical neurons by activating PI3K\/AKT\/NF-\u03baB\/CREB pathways","volume":"69","author":"Zhou","year":"2014","journal-title":"Cytokine"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1346-8138.2008.00513.x","article-title":"Interleukin-18 prevents apoptosis via PI3K\/Akt pathway in normal human keratinocytes","volume":"35","author":"Hosotani","year":"2008","journal-title":"J. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/jlb.64.4.519","article-title":"Interleukin-18\/interferon-\u03b3-inducing factor, a novel cytokine, up-regulates ICAM-1 (CD54) expression in KG-1 cells","volume":"64","author":"Kohka","year":"1998","journal-title":"J. Leukoc. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"37069","DOI":"10.1074\/jbc.M103574200","article-title":"A novel role for interleukin-18 in adhesion molecule induction through NF kappa B and phosphatidylinositol (PI) 3-kinase-dependent signal transduction pathways","volume":"276","author":"Morel","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.4049\/jimmunol.1103212","article-title":"Caspase-1 has both proinflammatory and regulatory properties in Helicobacter infections, which are differentially mediated by its substrates IL-1\u03b2 and IL-18","volume":"188","author":"Hitzler","year":"2012","journal-title":"J. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1020506300324","article-title":"Interleukin-18 and interleukin-1\u03b2: Two cytokine substrates for ICE (caspase-1)","volume":"19","author":"Fantuzzi","year":"1999","journal-title":"J. Clin. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.4049\/jimmunol.157.9.3967","article-title":"IFN-\u03b3-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones","volume":"157","author":"Tsutsui","year":"1996","journal-title":"J. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1002\/eji.201142173","article-title":"M-CSF induces the expression of a membrane-bound form of IL-18 in a subset of human monocytes differentiating in vitro toward macrophages","volume":"42","author":"Bellora","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0014-5793(99)00148-9","article-title":"Cloning and expression of interleukin-18 binding protein","volume":"445","author":"Aizawa","year":"1999","journal-title":"FEBS Lett."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"5913","DOI":"10.4049\/jimmunol.167.10.5913","article-title":"IL-18-binding protein protects against lipopolysaccharide- induced lethality and prevents the development of Fas\/Fas ligand-mediated models of liver disease in mice","volume":"167","author":"Faggioni","year":"2001","journal-title":"J. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1002\/eji.200425124","article-title":"Frontline: Interferon regulatory factor-1 as a protective gene in intestinal inflammation: Role of TCR \u03b3 \u03b4 T cells and interleukin-18-binding protein","volume":"34","author":"Siegmund","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.4049\/jimmunol.170.4.2100","article-title":"Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein","volume":"170","author":"Banda","year":"2003","journal-title":"J. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.clim.2004.11.007","article-title":"IL-18 binding protein fusion construct delays the development of diabetes in adoptive transfer and cyclophosphamide-induced diabetes in NOD mouse","volume":"115","author":"Zaccone","year":"2005","journal-title":"Clin. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Nold-Petry, C.A., Lehrnbecher, T., Jarisch, A., Schwabe, D., Pfeilschifter, J.M., Muhl, H., and Nold, M.F. (2010). Failure of interferon \u03b3 to induce the anti-inflammatory interleukin 18 binding protein in familial hemophagocytosis. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0008663"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jaut.2009.08.002","article-title":"High circulating levels of free interleukin-18 in patients with active SLE in the presence of elevated levels of interleukin-18 binding protein","volume":"34","author":"Novick","year":"2010","journal-title":"J. Autoimmun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"156890","DOI":"10.1155\/2012\/156890","article-title":"IL-18 Serum Level in Adult Onset Still\u2019s Disease: A Marker of Disease Activity","volume":"2012","author":"Colafrancesco","year":"2012","journal-title":"Int. J. Inflamm."},{"key":"ref_37","first-page":"840","article-title":"Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still\u2019s disease","volume":"77","author":"Gabay","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.jaci.2016.10.022","article-title":"Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition","volume":"139","author":"Canna","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"13723","DOI":"10.1073\/pnas.212519099","article-title":"A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity","volume":"99","author":"Bufler","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.imlet.2013.12.013","article-title":"Autoinflammatory diseases","volume":"161","author":"Rubartelli","year":"2014","journal-title":"Immunol. Lett."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e14696","DOI":"10.1111\/ped.14696","article-title":"Role of E148Q in familial Mediterranean fever with an exon 10 mutation in MEFV","volume":"64","author":"Miyashita","year":"2022","journal-title":"Pediatr. Int."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nrrheum.2011.68","article-title":"Pathogenesis of systemic juvenile idiopathic arthritis: Some answers, more questions","volume":"7","author":"Mellins","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.clim.2016.05.010","article-title":"Cytokine profile in adult-onset Still\u2019s disease: Comparison with systemic juvenile idiopathic arthritis","volume":"169","author":"Inoue","year":"2016","journal-title":"Clin. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1002\/art.34514","article-title":"Natural killer T cell deficiency in active adult-onset Still\u2019s Disease: Correlation of deficiency of natural killer T cells with dysfunction of natural killer cells","volume":"64","author":"Lee","year":"2012","journal-title":"Arthritis Rheum."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1067\/mpd.2003.110","article-title":"Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome","volume":"142","author":"Grom","year":"2003","journal-title":"J. Pediatr."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/1529-0131(200103)44:3<550::AID-ANR103>3.0.CO;2-5","article-title":"Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still\u2019s disease","volume":"44","author":"Kawashima","year":"2001","journal-title":"Arthritis Rheum."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/ped.13679","article-title":"Transient natural killer cell dysfunction associated with interleukin-18 overproduction in systemic juvenile idiopathic arthritis","volume":"60","author":"Takakura","year":"2018","journal-title":"Pediatr. Int."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/1529-0131(200104)44:4<884::AID-ANR145>3.0.CO;2-4","article-title":"A novel role for interleukin-18 in human natural killer cell death: High serum levels and low natural killer cell numbers in patients with systemic autoimmune diseases","volume":"44","author":"Shibatomi","year":"2001","journal-title":"Arthritis Rheum."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1002\/art.24750","article-title":"Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis","volume":"60","author":"Vastert","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/acr2.11426","article-title":"Impaired Interleukin-18 Signaling in Natural Killer Cells From Patients With Systemic Juvenile Idiopathic Arthritis","volume":"4","author":"Ohya","year":"2022","journal-title":"ACR Open Rheumatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1038\/s41598-017-04086-w","article-title":"Upregulation of circulating microRNA-134 in adult-onset Still\u2019s disease and its use as potential biomarker","volume":"7","author":"Liao","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1172\/JCI1379","article-title":"Interleukin-18 (IFN\u03b3-inducing factor) induces IL-8 and IL-1\u03b2 via TNF\u03b1 production from non-CD14+ human blood mononuclear cells","volume":"101","author":"Puren","year":"1998","journal-title":"J. Clin. Investig."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/rheumatology\/keu524","article-title":"Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: Tipping the balance between interleukin-18 and interferon-\u03b3","volume":"54","author":"Put","year":"2015","journal-title":"Rheumatology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fimmu.2019.00119","article-title":"The Immunology of Macrophage Activation Syndrome","volume":"10","author":"Crayne","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jpeds.2005.12.070","article-title":"Macrophage activation syndrome as the presenting manifestation of rheumatic diseases in childhood","volume":"148","author":"Tse","year":"2006","journal-title":"J. Pediatr."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-med-061813-012806","article-title":"Pathogenesis of Macrophage Activation Syndrome and Potential for Cytokine-Directed Therapies","volume":"66","author":"Schulert","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1182\/blood-2010-08-300046","article-title":"Gene expression profiling of peripheral blood mononuclear cells from children with active hemophagocytic lymphohistiocytosis","volume":"117","author":"Sumegi","year":"2011","journal-title":"Blood"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1182\/blood-2017-12-820852","article-title":"Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome","volume":"131","author":"Weiss","year":"2018","journal-title":"Blood"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/art.22644","article-title":"Specific gene expression profiles in systemic juvenile idiopathic arthritis","volume":"56","author":"Ogilvie","year":"2007","journal-title":"Arthritis Rheum."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1002\/1521-4141(200010)30:10<3057::AID-IMMU3057>3.0.CO;2-P","article-title":"Interleukin-18 induces production of proinflammatory cytokines in mice: No intermediate role for the cytokines of the tumor necrosis factor family and interleukin-1\u03b2","volume":"30","author":"Netea","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1182\/blood-2017-06-789552","article-title":"Unopposed IL-18 signaling leads to severe TLR9-induced macrophage activation syndrome in mice","volume":"131","author":"Palomo","year":"2018","journal-title":"Blood"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/art.39407","article-title":"Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab","volume":"68","author":"Grom","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.clim.2012.03.004","article-title":"Transient impairment of NK cell function in an infant born to a mother with adult-onset Still\u2019s disease: Perinatal effect of maternal IL-18","volume":"143","author":"Shimizu","year":"2012","journal-title":"Clin. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3899\/jrheum.140288","article-title":"Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis under Treatment with Tocilizumab","volume":"42","author":"Yokota","year":"2015","journal-title":"J. Rheumatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.clim.2015.06.005","article-title":"Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis","volume":"160","author":"Shimizu","year":"2015","journal-title":"Clin. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/annrheumdis-2019-216030","article-title":"Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis","volume":"79","author":"Lee","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e563","DOI":"10.1016\/S2665-9913(21)00115-6","article-title":"Definition and validation of serum biomarkers for optimal differentiation of hyperferritinaemic cytokine storm conditions in children: A retrospective cohort study","volume":"3","author":"Kessel","year":"2021","journal-title":"Lancet Rheumatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1093\/rheumatology\/keaa634","article-title":"Clinical significance of interleukin-18 for the diagnosis and prediction of disease course in systemic juvenile idiopathic arthritis","volume":"60","author":"Mizuta","year":"2021","journal-title":"Rheumatology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1002\/art.10389","article-title":"Highly elevated serum levels of interleukin-18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease: Comment on the article by Kawashima et al","volume":"46","author":"Maeno","year":"2002","journal-title":"Arthritis Rheum."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1093\/rheumatology\/kew300","article-title":"Elevated serum levels of free interleukin-18 in adult-onset Still\u2019s disease","volume":"55","author":"Rech","year":"2016","journal-title":"Rheumatology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1007\/s10067-006-0474-0","article-title":"Interleukin-18 as a mediator of systemic juvenile idiopathic arthritis","volume":"26","author":"Rudan","year":"2007","journal-title":"Clin. Rheumatol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41584-018-0081-x","article-title":"Mechanisms, biomarkers and targets for adult-onset Still\u2019s disease","volume":"14","author":"Feist","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jbspin.2017.05.011","article-title":"New Markers for Adult-Onset Still\u2019s Disease","volume":"85","author":"Mitrovic","year":"2018","journal-title":"Jt. Bone Spine"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Kudela, H., Drynda, S., Lux, A., Horneff, G., and Kekow, J. (2019). Comparative study of Interleukin-18 (IL-18) serum levels in adult onset Still\u2019s disease (AOSD) and systemic onset juvenile idiopathic arthritis (sJIA) and its use as a biomarker for diagnosis and evaluation of disease activity. BMC Rheumatol., 3.","DOI":"10.1186\/s41927-019-0053-z"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/rheumatology\/kez284","article-title":"IL-18 as therapeutic target in a patient with resistant systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome","volume":"59","author":"Yasin","year":"2020","journal-title":"Rheumatology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/abbs\/gmt007","article-title":"The imbalance of IL-18\/IL-18BP in patients with systemic juvenile idiopathic arthritis","volume":"45","author":"Chen","year":"2013","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/rheumatology\/keq133","article-title":"Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis","volume":"49","author":"Shimizu","year":"2010","journal-title":"Rheumatology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1182\/blood-2005-05-1980","article-title":"Severe imbalance of IL-18\/IL-18BP in patients with secondary hemophagocytic syndrome","volume":"106","author":"Mazodier","year":"2005","journal-title":"Blood"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/ng.3089","article-title":"An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome","volume":"46","author":"Canna","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature05257","article-title":"XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome","volume":"444","author":"Rigaud","year":"2006","journal-title":"Nature"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cyto.2013.09.007","article-title":"Sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency","volume":"65","author":"Wada","year":"2014","journal-title":"Cytokine"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1084\/jem.20190147","article-title":"A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function","volume":"216","author":"Lam","year":"2019","journal-title":"J. Exp. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jaci.2022.01.024","article-title":"Mutations at the C-terminus of CDC42 cause distinct hematopoietic and autoinflammatory disorders","volume":"150","author":"Coppola","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1182\/blood-2016-03-706028","article-title":"Cytoskeletal abnormalities and neutrophil dysfunction in WDR1 deficiency","volume":"128","author":"Kuhns","year":"2016","journal-title":"Blood"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"930141","DOI":"10.3389\/fimmu.2022.930141","article-title":"Immune-mediated inflammatory diseases with chronic excess of serum interleukin-18","volume":"13","author":"Miyazawa","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1084\/jem.20142384","article-title":"Aberrant actin depolymerization triggers the pyrin inflammasome and autoinflammatory disease that is dependent on IL-18, not IL-1\u03b2","volume":"212","author":"Kim","year":"2015","journal-title":"J. Exp. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"155302","DOI":"10.1016\/j.cyto.2020.155302","article-title":"Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19","volume":"137","author":"Gulbahar","year":"2021","journal-title":"Cytokine"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF03191127","article-title":"Pharmacokinetics of IL-18 binding protein in healthy volunteers and subjects with rheumatoid arthritis or plaque psoriasis","volume":"31","author":"Tak","year":"2006","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s10875-022-01236-2","article-title":"XIAP Deficiency Treatment Consortium A Case of XIAP Deficiency Successfully Managed with Tadekinig Alfa (rhIL-18BP)","volume":"42","author":"Geerlinks","year":"2022","journal-title":"J. Clin. Immunol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/BTT.S290329","article-title":"Progress in Biological Therapies for Adult-Onset Still\u2019s Disease","volume":"16","author":"Bindoli","year":"2022","journal-title":"Biol. Targets Ther."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10875-022-01353-y","article-title":"Improvement of Refractory Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease with Single-Agent Blockade of IL-1\u03b2 and IL-18","volume":"43","author":"Rood","year":"2023","journal-title":"J. Clin. Immunol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1158\/1078-0432.CCR-06-0121","article-title":"Clinical and Biological Effects of Recombinant Human Interleukin-18 Administered by Intravenous Infusion to Patients with Advanced Cancer","volume":"12","author":"Robertson","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"919973","DOI":"10.3389\/fimmu.2022.919973","article-title":"Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: Biological role in induction, regulation, and treatment","volume":"13","author":"Ihim","year":"2022","journal-title":"Front. Immunol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/13\/11125\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:06:40Z","timestamp":1760126800000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/13\/11125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,5]]},"references-count":93,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["ijms241311125"],"URL":"https:\/\/doi.org\/10.3390\/ijms241311125","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,5]]}}}